Tinengotinib, a novel fibroblast growth factor receptor (FGFR) inhibitor, is potent against resistance mutations in FGFR1/2/3

被引：1
|
作者：
Qiang, Xiaoyan
Yu, Qi
Fan, Jean
Wu, Frank
Sun, Caixia
Peng, Peng
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-LB229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB229
引用
收藏
页数：2
相关论文
共 50 条
  • [1] MAb Against Fibroblast Growth Factor Receptor 1 (FGFR1)
    Filonenko, Valeriy
    HYBRIDOMA, 2009, 28 (04): : 302 - 302
  • [2] Tinengotinib in patients with advanced, fibroblast growth factor receptor (FGFR) inhibitor refractory/relapsed cholangiocarcinoma
    Javle, M.
    Fonkoua, L. A. Kankeu
    Mahipal, A.
    Liao, C-Y.
    Fountzilas, C.
    Li, D.
    Pelster, M. S.
    Goel, S.
    Peng, P.
    Sun, C.
    Wang, H.
    Hennessy, K.
    Fu, X.
    Neo, L.
    Shan, Y.
    Huang, P.
    Wu, D.
    Wu, F.
    Fan, J.
    Piha-Paul, S. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S215 - S216
  • [3] Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face
    Wilke, TA
    Gubbels, S
    Schwartz, J
    Richman, JM
    DEVELOPMENTAL DYNAMICS, 1997, 210 (01) : 41 - 52
  • [4] Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1)
    Zenaty, Delphine
    Bretones, Patricia
    Lambe, Cecile
    Guemas, Isabelle
    David, Michel
    Leger, Juliane
    de Roux, Nicolas
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 254 : 78 - 83
  • [5] Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor
    Wu, Liangxing
    Zhang, Colin
    He, Chunhong
    Qian, Dingquan
    Lu, Liang
    Sun, Yaping
    Xu, Meizhong
    Zhuo, Jincong
    Liu, Phillip C. C.
    Klabe, Ronald
    Wynn, Richard
    Covington, Maryanne
    Gallagher, Karen
    Leffet, Lynn
    Bowman, Kevin
    Diamond, Sharon
    Koblish, Holly
    Zhang, Yue
    Soloviev, Maxim
    Hollis, Gregory
    Burn, Timothy C.
    Scherle, Peggy
    Yeleswaram, Swamy
    Huber, Reid
    Yao, Wenqing
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) : 10666 - 10679
  • [6] Fibroblast growth factor receptor 1 (FGFR1) is over-expressed in benign prostatic hyperplasia whereas FGFR2-IIIc and FGFR3 are not
    Boget, S
    Cereser, C
    Parvaz, P
    Leriche, A
    Revol, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (03) : 303 - 310
  • [7] The prevalence of fibroblast growth factor receptor-1 (FGFR1) mutations in patients with Kallmann syndrome.
    Gleason, JL
    Xu, N
    Layman, LC
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (02) : 235A - 235A
  • [8] Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma
    Tsimafeyeu, Ilya
    Demidov, Lev
    Stepanova, Eugenia
    Wynn, Nigel
    Ta, Hung
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2011, 45 (03): : 190 - 195
  • [9] Fibroblast growth factor receptor 1 (Fgfr1) participates in postnatal interneuron development
    Smith, K. M.
    Maragnoli, M. E.
    Phull, P. M.
    Tran, K. M.
    Vaccarino, F. M.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2010, 28 (08) : 698 - 698
  • [10] Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors
    Tajima, Shogo
    Fukayama, Masashi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (08): : 9422 - 9427
12345